National and Kapodistrian University of Athens
Προγνωστικοί παράγοντες επιβίωσης σε ασθενείς χειρουργηθέντες με καρκίνο παχέος εντέρου
Abstract
dc:descriptionThe clinical prediction of survival remains one of the significant challenges for clinicians as it greatly influences the therapeutic intervention and the management of out of hospital patient care. The aim of the study was to identify the prognostic value of clinical, lab based and pathology parametres in patients with colon cancer. This study is retrospective with a total of 291 patients, where 25 parametres were examined using a regression statistical model to identify relevant prognostic parametres that relate to overall survival and disease free survival. All the patients in the study received standard adjuvant chemotherapy and were under follow up from the diagnosis until the end date of the study Our analysis showed that the following parameters were significant prognostic factors. Patients with stage B disease had mean overall survival of 146 months with 5-year survival rate of 86.1%, while Duke’s C patients had mean overall survival of 117 months with 66.0% 5-year survival rate. Duke’s C patients had 3 times higher probability of relapse ([HR], 2.918, 95% CI, 1.52-5.605; P < .001) and 3.1 higher risk of death ([HR], 3.1; 95% CI, 1.6- 6.01 ; P < .001). Patients with performance status < 90 had mean survival 54 months while patients with PS > 90 had mean survival 139 months (p<0.001), Patients with PS <90 had 3.67 higher risk of death < 90 ([HR], ; 3,67 95% CI, 2,38-5.67; P < 0.001). Lymph node evaluation proved to be a significant prognostic factor. Patients who had less than 12 lymph nodes resected had 2.07 higher risk of relapse( [HR], 2.07; 95% CI, 1.139-3.768 ; P < .017). Duke’s C patients with less than 8 lymph nodes evaluated had 50.2 % 5-year survival rate in comparison with71.8 % 5-year survival rate in patients with more than 8 lymph nodes (p<0.03). The lymph node ratio (ratio of positive lymph nodes over the total number evaluated) showed prognostic significance. Patients with the highest LNR>0.4 had mean overall survival of 43 months where as patients with the lowest LNR<0.19 had mean survival of 172 months (p<0.001). Patients who had positive tumor markers had 2.3 higher risk of deadth ([HR], 2.3; 95% CI, 1.46- 3.75 ; P < .001) and 2.7 higher risk of relapse ([HR], 2.78 ; 95% CI, 1.13- 3.768 ; P < .001). Anaemia during therapy and follow up was found to relate with prognosis. The Hb level was inversely related with risk of death [HR], 0.867; 95% CI, 0,825-0.913; P < .0001) and relapse ([HR], 0.837 ; 95% CI, 0.776-0.904; P < .0001). Patients with smoking history (over 10 pack/year) had 2.42 higher risk of relapse in comparison to patients with no smoking history (HR 2.42 p < 0.015, 95% CI, 1.18-4.97). Tumour differentiation had a marginal relation to the overall survival but not to disease free survival. Ιn our study patients with high grade differentiation had mean overall survival 96 months while patients with low grade tumours had mean overall survival 138 months (p<0.04) It is deducted that low performance status, (PS<90) , advanced disease, anaemia, a high ratio of positive lymph nodes to total lymph nodes assessed, small number of lymph nodes identified and assessed, smoking and high tumour markers are markers that reliably predict prognosis of colon cancer patients , enabling clinicians decide on clinical management and overall care of these patients.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2010
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Διαμαντής, Νικόλαος
- Diamantis, Nikolaos
Subjects
dc:subject × 18- Καρκίνος παχέος εντέρου
- Στάδιο B2 και C
- Υποτροπή
- Συνολική επιβίωση
- Κάπνισμα
- Λεμφαδένες
- Επιβίωση ελεύθερης νόσου
- Colorectal cancer
- Prognostic factors
- Survival
- Smoking
- Recurrence
- Disease free survival ( DFS)
- Lymph node ratio
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες Υγείας
- Medical and Health Sciences
- Health Sciences
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/28718